IGF1 and Parkinson disease: This study aimed to evaluate the serum levels of systemic inflammatory markers, such as NLR, NHR, MHR, PLR, IL-6, IGF-1, HDL, SII, and SIRI, in patients with PD and to investigate their association between these markers and the clinical stage of the disease, as well as motor and non-motor symptoms.